Inhibition of connexin43 gap junction channels by the endocrine disruptor ioxynil

Toxicology and Applied Pharmacology

Volumn 247, Issue 1, 2010, Pages 10-17

  Leithe, Edward ^a   Kjenseth, Ane ^a   Bruun, Jarle ^a   Sirnes, Solveig ^a   Rivedal, Edgar ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Connexin43; Endocrine disruptor; Gap junction; Ioxynil; Ioxynil octanoate; Non genotoxic carcinogen

Indexed keywords

CONNEXIN 43; ENDOCRINE DISRUPTOR; IOXYNIL; IOXYNIL OCTANOATE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PESTICIDE; UNCLASSIFIED DRUG; IODOBENZENE; NITRILE;

ANIMAL CELL; ARTICLE; BIOASSAY; CARCINOGENIC ACTIVITY; CELL COMMUNICATION; CELL MEMBRANE; CHEMICAL STRUCTURE; CONTROLLED STUDY; GAP JUNCTION; GENOTOXICITY; MOLECULAR MECHANICS; NONHUMAN; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN PHOSPHORYLATION; RAT; RISK ASSESSMENT; THYROID GLAND; ANIMAL; CELL JUNCTION; CELL LINE; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM;

ANIMALIA;

ANIMALS; CELL LINE; CONNEXIN 43; ENDOCRINE DISRUPTORS; GAP JUNCTIONS; IODOBENZENES; NITRILES; RATS;

EID: 77954763122     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2010.05.006     Document Type: Article

References (50)

1. Avanzo J.L., Mesnil M., Hernandez-Blazquez F.J., Mackowiak I.I., Mori C.M., da Silva T.C., Oloris S.C., Garate A.P., Massironi S.M., Yamasaki H., Dagli M.L. Increased susceptibility to urethane-induced lung tumors in mice with decreased expression of connexin43. Carcinogenesis 2004, 25:1973-1982.
2. Chadjichristos C.E., Derouette J.P., Kwak B.R. Connexins in atherosclerosis. Advances in Cardiology 2006, 42:255-267.
3. Dagli M.L., Yamasaki H., Krutovskikh V., Omori Y. Delayed liver regeneration and increased susceptibility to chemical hepatocarcinogenesis in transgenic mice expressing a dominant-negative mutant of connexin32 only in the liver. Carcinogenesis 2004, 25:483-492.
4. Eghbali B., Kessler J.A., Reid L.M., Roy C., Spray D.C. Involvement of gap junctions in tumorigenesis: transfection of tumor cells with connexin 32 cDNA retards growth in vivo. Proceedings of the National Academy of Sciences of the United States of America 1991, 88:10701-10705.
5. Goldberg G.S., Bechberger J.F., Tajima Y., Merritt M., Omori Y., Gawinowicz M.A., Narayanan R., Tan Y., Sanai Y., Yamasaki H., Naus C.C., Tsuda H., Nicholson B.J. Connexin43 suppresses MFG-E8 while inducing contact growth inhibition of glioma cells. Cancer Research 2000, 60:6018-6026.
6. Hossain M.Z., Jagdale A.B., Ao P., Boynton A.L. Mitogen-activated protein kinase and phosphorylation of connexin43 are not sufficient for the disruption of gap junctional communication by platelet-derived growth factor and tetradecanoylphorbol acetate. Journal of Cellular Physiology 1999, 179:87-96.
7. Ishihara A., Nishiyama N., Sugiyama S., Yamauchi K. The effect of endocrine disrupting chemicals on thyroid hormone binding to Japanese quail transthyretin and thyroid hormone receptor. Gen. Comp Endocrinol. 2003, 134:36-43.
8. King T.J., Lampe P.D. Mice deficient for the gap junction protein Connexin32 exhibit increased radiation-induced tumorigenesis associated with elevated mitogen-activated protein kinase (p44/Erk1, p42/Erk2) activation. Carcinogenesis 2004, 25:669-680.
9. Kjenseth A., Fykerud T., Rivedal E., Leithe E. Regulation of gap junction intercellular communication by the ubiquitin system. Cell Signal. 2010.
10. Krysko D.V., Leybaert L., Vandenabeele P., D'Herde K. Gap junctions and the propagation of cell survival and cell death signals. Apoptosis 2005, 10:459-469.
11. Lampe P.D., Lau A.F. The effects of connexin phosphorylation on gap junctional communication. Int. J. Biochem. Cell Biol. 2004, 36:1171-1186.
12. Langlois S., Cowan K.N., Shao Q., Cowan B.J., Laird D.W. The Tumor-Suppressive Function of Connexin43 in Keratinocytes Is Mediated in Part via Interaction with Caveolin-1. Cancer Research 2010.
13. Leithe E., Rivedal E. Epidermal growth factor regulates ubiquitination, internalization and proteasome-dependent degradation of connexin43. Journal of Cell Science 2004, 117:1211-1220.
14. Leithe E., Rivedal E. Ubiquitination and down-regulation of gap junction protein connexin-43 in response to 12-O-tetradecanoylphorbol 13-acetate treatment. Journal of Biological Chemistry 2004, 279:50089-50096.
15. Leithe E., Cruciani V., Sanner T., Mikalsen S.O., Rivedal E. Recovery of gap junctional intercellular communication after phorbol ester treatment requires proteasomal degradation of protein kinase C. Carcinogenesis 2003, 24:1239-1245.
16. Leithe E., Brech A., Rivedal E. Endocytic processing of connexin43 gap junctions: a morphological study. Biochemical Journal 2006, 393:59-67.
17. Leithe E., Sirnes S., Omori Y., Rivedal E. Downregulation of gap junctions in cancer cells. Crit. Rev. Oncog. 2006, 12:225-256.
18. Leithe E., Kjenseth A., Sirnes S., Stenmark H., Brech A., Rivedal E. Ubiquitylation of the gap junction protein connexin-43 signals its trafficking from early endosomes to lysosomes in a process mediated by Hrs and Tsg101. Journal of Cell Science 2009, 122:3883-3893.
19. Lin Z.X., Kavanagh T., Trosko J.E., Chang C.C. Inhibition of gap junctional intercellular communication in human teratocarcinoma cells by organochlorine pesticides. Toxicol. Appl. Pharmacol. 1986, 83:10-19.
20. Lin J.H., Yang J., Liu S., Takano T., Wang X., Gao Q., Willecke K., Nedergaard M. Connexin mediates gap junction-independent resistance to cellular injury. Journal of Neuroscience 2003, 23:430-441.
21. Luch A. Nature and nurture-lessons from chemical carcinogenesis. Nat. Rev. Cancer 2005, 5:113-125.
22. Malarkey D.E., Devereux T.R., Dinse G.E., Mann P.C., Maronpot R.R. Hepatocarcinogenicity of chlordane in B6C3F1 and B6D2F1 male mice: evidence for regression in B6C3F1 mice and carcinogenesis independent of ras proto-oncogene activation. Carcinogenesis 1995, 16:2617-2625.
23. Masten S.J., Tian M., Upham B.L., Trosko J.E. Effect of selected pesticides and their ozonation by-products on gap junctional intercellular communication using rat liver epithelial cell lines. Chemosphere 2001, 44:457-465.
24. McKinlay R., Plant J.A., Bell J.N., Voulvoulis N. Endocrine disrupting pesticides: implications for risk assessment. Environ. Int. 2008, 34:168-183.
25. Mesnil M. Connexins Cancer. Biol. Cell 2002, 94:493-500.
26. Montesano R., Saint V.L., Drevon C., Tomatis L. Production of epithelial and mesenchymal tumours with rat liver cells transformed in vitro. International Journal of Cancer 1975, 16:550-558.
27. Morgado I., Hamers T., van D.V., Power D.M. Disruption of thyroid hormone binding to sea bream recombinant transthyretin by ioxinyl and polybrominated diphenyl ethers. Chemosphere 2007, 69:155-163.
28. Omori Y., Yamasaki H. Gap junction proteins connexin32 and connexin43 partially acquire growth-suppressive function in HeLa cells by deletion of their C-terminal tails. Carcinogenesis 1999, 20:1913-1918.
29. Opsahl H., Rivedal E. Quantitative determination of gap junction intercellular communication by scrape loading and image analysis. Cell Adhes. Commun. 2000, 7:367-375.
30. Qin H., Shao Q., Curtis H., Galipeau J., Belliveau D.J., Wang T., Alaoui-Jamali M.A., Laird D.W. Retroviral delivery of connexin genes to human breast tumor cells inhibits in vivo tumor growth by a mechanism that is independent of significant gap junctional intercellular communication. Journal of Biological Chemistry 2002, 277:29132-29138.
31. Report Directorate, E. Review report for the active substance ioxynil 2004, European Commission.
32. Rivedal E., Leithe E. Connexin43 synthesis, phosphorylation, and degradation in regulation of transient inhibition of gap junction intercellular communication by the phorbol ester TPA in rat liver epithelial cells. Experimental Cell Research 2005, 302:143-152.
33. Rivedal E., Opsahl H. Role of PKC and MAP kinase in EGF- and TPA-induced connexin43 phosphorylation and inhibition of gap junction intercellular communication in rat liver epithelial cells. Carcinogenesis 2001, 22:1543-1550.
34. Rosenkranz H.S., Pollack N., Cunningham A.R. Exploring the relationship between the inhibition of gap junctional intercellular communication and other biological phenomena. Carcinogenesis 2000, 21:1007-1011.
35. Ruch R.J., Fransson R., Flodstrom S., Warngard L., Klaunig J.E. Inhibition of hepatocyte gap junctional intercellular communication by endosulfan, chlordane and heptachlor. Carcinogenesis 1990, 11:1097-1101.
36. Rummel A.M., Trosko J.E., Wilson M.R., Upham B.L. Polycyclic aromatic hydrocarbons with bay-like regions inhibited gap junctional intercellular communication and stimulated MAPK activity. Toxicol. Sci. 1999, 49:232-240.
37. Saez J.C., Berthoud V.M., Branes M.C., Martinez A.D., Beyer E.C. Plasma membrane channels formed by connexins: their regulation and functions. Physiol. Rev. 2003, 83:1359-1400.
38. Segretain D., Falk M.M. Regulation of connexin biosynthesis, assembly, gap junction formation, and removal. Biochimica et Biophysica Acta 2004, 1662:3-21.
39. Sirnes S., Leithe E., Rivedal E. The detergent resistance of Connexin43 is lost upon TPA or EGF treatment and is an early step in gap junction endocytosis. Biochemical and Biophysical Research Communications 2008, 373:597-601.
40. Sirnes S., Kjenseth A., Leithe E., Rivedal E. Interplay between PKC and the MAP kinase pathway in Connexin43 phosphorylation and inhibition of gap junction intercellular communication. Biochemical and Biophysical Research Communications 2009, 382:41-45.
41. Solan J.L., Lampe P.D. Connexin43 phosphorylation: structural changes and biological effects. Biochemical Journal 2009, 419:261-272.
42. Sugiyama S., Shimada N., Miyoshi H., Yamauchi K. Detection of thyroid system-disrupting chemicals using in vitro and in vivo screening assays in Xenopus laevis. Toxicol. Sci. 2005, 88:367-374.
43. Temme A., Buchmann A., Gabriel H.D., Nelles E., Schwarz M., Willecke K. High incidence of spontaneous and chemically induced liver tumors in mice deficient for connexin32. Curr. Biol. 1997, 7:713-716.
44. Trosko J.E., Ruch R.J. Cell-cell communication in carcinogenesis [In Process Citation]. Front Biosci. 1998, 3:D208-D236.
45. Upham B.L., Blaha L., Babica P., Park J.S., Sovadinova I., Pudrith C., Rummel A.M., Weis L.M., Sai K., Tithof P.K., Guzvic M., Vondracek J., Machala M., Trosko J.E. Tumor promoting properties of a cigarette smoke prevalent polycyclic aromatic hydrocarbon as indicated by the inhibition of gap junctional intercellular communication via phosphatidylcholine-specific phospholipase C. Cancer Sci. 2008, 99:696-705.
46. VanSlyke J.K., Musil L.S. Cytosolic stress reduces degradation of connexin43 internalized from the cell surface and enhances gap junction formation and function. Molecular Biology of the Cell 2005, 16:5247-5257.
47. Warn-Cramer B.J., Lau A.F. Regulation of gap junctions by tyrosine protein kinases. Biochimica et Biophysica Acta 2004, 1662:81-95.
48. Wei C.J., Xu X., Lo C.W. Connexins and cell signaling in development and disease. Annu. Rev. Cell Dev. Biol. 2004, 20:811-838.
49. Willecke K., Eiberger J., Degen J., Eckardt D., Romualdi A., Guldenagel M., Deutsch U., Sohl G. Structural and functional diversity of connexin genes in the mouse and human genome. Biol. Chem. 2002, 383:725-737.
50. Yamasaki H., Naus C.C. Role of connexin genes in growth control. Carcinogenesis 1996, 17:1199-1213.